From Casetext: Smarter Legal Research

UCB, Inc. v. Annora Pharma. Private Ltd.

United States Court of Appeals, Federal Circuit
Nov 21, 2023
No. 2024-1056 (Fed. Cir. Nov. 21, 2023)

Opinion

2024-1056

11-21-2023

UCB, INC., UCB BIOPHARMA SRL, Plaintiffs-Appellees v. ANNORA PHARMA PRIVATE LIMITED, APOTEX INC., APOTEX CORP., Defendants MSN PHARMACEUTICALS, INC., MSN LABORATORIES PRIVATE LTD., Defendants-Appellants


NOTE: This order is nonprecedential.

Appeal from the United States District Court for the District of Delaware in No. 1:20-cv-00987-CFC-JLH, 1:20-cv-01343-CFC, Chief Judge Colm F. Connolly.

ORDER

The parties having so agreed, it is ordered that:

(1) The proceeding is DISMISSED under Fed. R. App. P. 42 (b).

(2) Each side shall bear their own costs.


Summaries of

UCB, Inc. v. Annora Pharma. Private Ltd.

United States Court of Appeals, Federal Circuit
Nov 21, 2023
No. 2024-1056 (Fed. Cir. Nov. 21, 2023)
Case details for

UCB, Inc. v. Annora Pharma. Private Ltd.

Case Details

Full title:UCB, INC., UCB BIOPHARMA SRL, Plaintiffs-Appellees v. ANNORA PHARMA…

Court:United States Court of Appeals, Federal Circuit

Date published: Nov 21, 2023

Citations

No. 2024-1056 (Fed. Cir. Nov. 21, 2023)